Gastroesophageal Reflux Diseases Devices Market size in terms of volume and value 2016-2026
A chronic digestive disease that occurs when gastric juices or the stomach content flow back to the esophagus is known as Gastroesophageal reflux disease. It is also known as esophagitis reflux. The reflux causes irritation to the lining of the esophagus which leads to Gastroesophageal reflux diseases (GERD). Some of the common symptoms involved in GERD are heart burn, acid reflux etc. The discomfort caused due to GERD can be managed by modification in the life style, if GERD is in the primary stage. The actual mechanism is that reflux arises in order to maintain balance between the Lower esophageal sphincter pressure and the intra gastric pressure. Most commonly patients suffering from GERD have lowered Lower esophageal sphincter fault. Conversely, some patients have irregular pattern of sphincter relaxing and normal Lower esophageal sphincter pressures, resulting into gastric reflux. There are two ways of treating the disease depending upon the severity of the disease. If the GERD is at the primary stage it can be treated with the help of Antacids, H2-receptor antagonists, as well as dietary and lifestyle modifications. The patients who fail to respond to this therapy are then treated with Proton Pump Inhibitors. If this standard medical therapy fails to give results then devices are used to treat the disease. There are several invasive and noninvasive techniques through which Gastroesophageal reflux diseases can be treated. The minimally invasive surgeries include Linx, Endocinch endoluminal gastroplication, Esophy X etc. The noninvasive techniques includes Stretta technique.
A chronic digestive disease that occurs when gastric juices or the stomach content flow back to the esophagus is known as Gastroesophageal reflux disease. It is also known as esophagitis reflux. The reflux causes irritation to the lining of the esophagus which leads to Gastroesophageal reflux diseases (GERD). Some of the common symptoms involved in GERD are heart burn, acid reflux etc. The discomfort caused due to GERD can be managed by modification in the life style, if GERD is in the primary stage. The actual mechanism is that reflux arises in order to maintain balance between the Lower esophageal sphincter pressure and the intra gastric pressure. Most commonly patients suffering from GERD have lowered Lower esophageal sphincter fault. Conversely, some patients have irregular pattern of sphincter relaxing and normal Lower esophageal sphincter pressures, resulting into gastric reflux. There are two ways of treating the disease depending upon the severity of the disease. If the GERD is at the primary stage it can be treated with the help of Antacids, H2-receptor antagonists, as well as dietary and lifestyle modifications. The patients who fail to respond to this therapy are then treated with Proton Pump Inhibitors. If this standard medical therapy fails to give results then devices are used to treat the disease. There are several invasive and noninvasive techniques through which Gastroesophageal reflux diseases can be treated. The minimally invasive surgeries include Linx, Endocinch endoluminal gastroplication, Esophy X etc. The noninvasive techniques includes Stretta technique.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Global<br />
<strong>Gastroesophageal</strong><br />
<strong>Reflux</strong> <strong>Diseases</strong><br />
<strong>Devices</strong> <strong>Market</strong><br />
Share, Global Trends,<br />
Analysis, Research, Report,<br />
Opportunities,<br />
Segmentation <strong>and</strong> Forecast,<br />
<strong>2016</strong> – <strong>2026</strong><br />
Future <strong>Market</strong> Insights<br />
www.futuremarket<strong>in</strong>sights.com<br />
sales@futuremarket<strong>in</strong>sights.com
Report Description<br />
A chronic digestive disease that occurs when gastric juices or the stomach content flow back to the<br />
esophagus is known as <strong>Gastroesophageal</strong> reflux disease. It is also known as esophagitis reflux. The reflux<br />
causes irritation to the l<strong>in</strong><strong>in</strong>g <strong>of</strong> the esophagus which leads to <strong>Gastroesophageal</strong> reflux diseases (GERD).<br />
Some <strong>of</strong> the common symptoms <strong>in</strong>volved <strong>in</strong> GERD are heart burn, acid reflux etc. The discomfort caused due<br />
to GERD can be managed by modification <strong>in</strong> the life style, if GERD is <strong>in</strong> the primary stage. The actual<br />
mechanism is that reflux arises <strong>in</strong> order to ma<strong>in</strong>ta<strong>in</strong> balance between the Lower esophageal sph<strong>in</strong>cter<br />
pressure <strong>and</strong> the <strong>in</strong>tra gastric pressure. Most commonly patients suffer<strong>in</strong>g from GERD have lowered Lower<br />
esophageal sph<strong>in</strong>cter fault. Conversely, some patients have irregular pattern <strong>of</strong> sph<strong>in</strong>cter relax<strong>in</strong>g <strong>and</strong> normal<br />
Lower esophageal sph<strong>in</strong>cter pressures, result<strong>in</strong>g <strong>in</strong>to gastric reflux. There are two ways <strong>of</strong> treat<strong>in</strong>g the<br />
disease depend<strong>in</strong>g upon the severity <strong>of</strong> the disease. If the GERD is at the primary stage it can be treated with<br />
the help <strong>of</strong> Antacids, H2-receptor antagonists, as well as dietary <strong>and</strong> lifestyle modifications. The patients who<br />
fail to respond to this therapy are then treated with Proton Pump Inhibitors. If this st<strong>and</strong>ard medical therapy<br />
fails to give results then devices are used to treat the disease. There are several <strong>in</strong>vasive <strong>and</strong> non<strong>in</strong>vasive<br />
techniques through which <strong>Gastroesophageal</strong> reflux diseases can be treated. The m<strong>in</strong>imally <strong>in</strong>vasive surgeries<br />
<strong>in</strong>clude L<strong>in</strong>x, Endoc<strong>in</strong>ch endolum<strong>in</strong>al gastroplication, Esophy X etc. The non<strong>in</strong>vasive techniques <strong>in</strong>cludes<br />
Stretta technique.<br />
LINX <strong>Reflux</strong> Management System consist <strong>of</strong> a small b<strong>and</strong> <strong>of</strong> <strong>in</strong>terwoven titanium beads (magnetically<br />
covered) <strong>and</strong> is flexible <strong>in</strong> nature. These b<strong>and</strong>s are laparoscopically positioned around the esophagus <strong>in</strong> such<br />
a way that it is just above the stomach. The LINX system enlarges while swallow<strong>in</strong>g that allows food <strong>and</strong><br />
liquid to pass normally <strong>in</strong>to the stomach. After the food <strong>and</strong> liquid is passed through the esophagus <strong>and</strong><br />
entered <strong>in</strong> to the stomach the attractive forces <strong>of</strong> the magnet closes the L<strong>in</strong>x system which prevents the<br />
reflux.
Report Description<br />
Request Free Report Sample@ http://www.futuremarket<strong>in</strong>sights.com/reports/sample/rep-gb-1741<br />
Esophy X TIF which is Trans oral Incision less Fundoplication is a surgical process performed through the<br />
mouth. It recreates the impediment between the stomach <strong>and</strong> esophagus. This prevent the reflux <strong>of</strong> the<br />
stomach fluids <strong>in</strong> esophagus. This is an <strong>in</strong>novative procedure that treats GERD by <strong>in</strong>directly reconstruct<strong>in</strong>g<br />
the anti-reflux valve. This restores the natural tendency <strong>of</strong> the body to control the reflux. It is completely<br />
non<strong>in</strong>vasive without any visible scars.<br />
The Stretta system distributes radio frequency to the part <strong>of</strong> muscle between the stomach <strong>and</strong> esophagus.<br />
This improves the function<strong>in</strong>g <strong>of</strong> the muscle tissue which <strong>in</strong> turn result<strong>in</strong>g <strong>in</strong> fewer reflux events <strong>and</strong><br />
improved barrier function. It treats the root cause responsible for <strong>Gastroesophageal</strong> reflux diseases without<br />
any surgery.<br />
<strong>Gastroesophageal</strong> <strong>Reflux</strong> <strong>Diseases</strong> <strong>Devices</strong> <strong>Market</strong>: Drivers <strong>and</strong> Restra<strong>in</strong>ts<br />
There are <strong>in</strong>creas<strong>in</strong>g <strong>in</strong>cidence <strong>of</strong> patients <strong>of</strong> GERD. There are several factors lead<strong>in</strong>g to GERD like Spicy food,<br />
Fast foods, aerated dr<strong>in</strong>ks, obesity, pregnancy, certa<strong>in</strong> medications, such as asthma medications, calcium<br />
channel blockers, <strong>and</strong> many antihistam<strong>in</strong>es, pa<strong>in</strong> killers, sedatives, <strong>and</strong> antidepressants, smok<strong>in</strong>g or <strong>in</strong>hal<strong>in</strong>g<br />
secondh<strong>and</strong> smoke. Also the consumption <strong>of</strong> aerated dr<strong>in</strong>ks is <strong>in</strong>creas<strong>in</strong>g to more GERD problems. These are<br />
few factors responsible for the growth <strong>of</strong> GERD <strong>Devices</strong> <strong>Market</strong>. Whereas very few cl<strong>in</strong>ical success <strong>of</strong> the<br />
medical device for the treatment along with considerable side effects is restra<strong>in</strong><strong>in</strong>g the growth <strong>of</strong><br />
<strong>Gastroesophageal</strong> <strong>Reflux</strong> <strong>Diseases</strong> <strong>Devices</strong> <strong>Market</strong>.
Report Description<br />
<strong>Gastroesophageal</strong> <strong>Reflux</strong> <strong>Diseases</strong> <strong>Devices</strong> <strong>Market</strong>: Segmentation<br />
Based on the surgery type, gastro esophageal reflux diseases devices market can be segment as:<br />
• Invasive<br />
o<br />
o<br />
L<strong>in</strong>x <strong>Reflux</strong> Management<br />
Medigus Ultrasonic Surgical Endostapler<br />
• Non Invasive<br />
o<br />
o<br />
o<br />
Endoc<strong>in</strong>ch ENdolumm<strong>in</strong>al gastroplication<br />
Stretta<br />
Esophy X<br />
Based <strong>in</strong> the region gastro esophageal reflux diseases devices market can be segment as<br />
• North America<br />
• Lat<strong>in</strong> America
Based on geographic regions, gastroesophageal reflux disease devices market is segmented <strong>in</strong>to seven key<br />
regions: North America, Lat<strong>in</strong> America, Europe, APAC <strong>and</strong> Middle East & Africa. North America seized major<br />
share <strong>in</strong> the global market <strong>of</strong> gastroesophageal reflux disease devices market due to <strong>in</strong>crease <strong>in</strong> ag<strong>in</strong>g<br />
population <strong>and</strong> awareness <strong>of</strong> drug therapies followed by Western <strong>and</strong> Eastern Europe, Asia Pacific may have<br />
a negative impact on GERD <strong>in</strong> their daily lives due to which the acceptance rate <strong>of</strong> therapy is low <strong>and</strong> the<br />
prevalence <strong>in</strong> Asia pacific is low as well.<br />
• Europe<br />
• APAC<br />
• MEA<br />
Report Description<br />
Request For TOC@ http://www.futuremarket<strong>in</strong>sights.com/toc/rep-gb-1741<br />
<strong>Gastroesophageal</strong> <strong>Reflux</strong> <strong>Diseases</strong> <strong>Devices</strong> <strong>Market</strong>: Overview<br />
<strong>Gastroesophageal</strong> reflux disease devices market is predicted to <strong>in</strong>crease dur<strong>in</strong>g the forecast period due to<br />
the extensive research <strong>and</strong> regulations <strong>in</strong> the field <strong>of</strong> <strong>Gastroesophageal</strong> reflux Disease <strong>Market</strong>. Though there<br />
are several available treatment us<strong>in</strong>g the devices along with number <strong>of</strong> side-effects. Hence Innovations <strong>in</strong><br />
<strong>terms</strong> <strong>of</strong> treatment modalities <strong>and</strong> commercialization <strong>of</strong> cost effective devices are expected to boost<br />
gastroesophageal reflux disease devices market dur<strong>in</strong>g the forecast period.<br />
<strong>Gastroesophageal</strong> <strong>Reflux</strong> <strong>Diseases</strong> <strong>Devices</strong> <strong>Market</strong>: Region-wise Outlook
Report Description<br />
The gastroesophageal reflux disease therapeutics market <strong>in</strong> japan will have a constant growth due to the<br />
balance between therapies <strong>and</strong> change <strong>in</strong> life style. Middle East <strong>and</strong> Africa holds promis<strong>in</strong>g future for rise <strong>in</strong><br />
the global gastroesophageal reflux disease therapeutics market as expenditure on healthcare from foreign<br />
countries is <strong>in</strong>creas<strong>in</strong>g which is favour<strong>in</strong>g the new drug development.<br />
<strong>Gastroesophageal</strong> <strong>Reflux</strong> <strong>Diseases</strong> <strong>Devices</strong> <strong>Market</strong>: Key Players<br />
The research report presents a comprehensive assessment <strong>of</strong> the market <strong>and</strong> conta<strong>in</strong>s thoughtful <strong>in</strong>sights,<br />
facts, historical data, <strong>and</strong> statistically supported <strong>and</strong> <strong>in</strong>dustry-validated market data. It also conta<strong>in</strong>s<br />
projections us<strong>in</strong>g a suitable set <strong>of</strong> assumptions <strong>and</strong> methodologies. The research report provides analysis<br />
<strong>and</strong> <strong>in</strong>formation accord<strong>in</strong>g to categories such as market segments, geographies, types, technology <strong>and</strong><br />
applications. Few competitors <strong>in</strong> the market are Torax® Medical, Inc., C. R. Bard, Inc. MEDERI THERAPEUTICS<br />
INC., EndoGastric Solutions <strong>and</strong> Medigus Ltd.<br />
Browse Full Report@ http://www.futuremarket<strong>in</strong>sights.com/reports/gastroesophageal-reflux-diseasesdevices-market
Customized<br />
Research<br />
Syndicated<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Future <strong>Market</strong> Insights (FMI) is a premier provider <strong>of</strong> syndicated research reports, custom research reports, <strong>and</strong> consult<strong>in</strong>g<br />
services. We deliver a complete packaged solution, which comb<strong>in</strong>es current market <strong>in</strong>telligence, statistical anecdotes,<br />
technology <strong>in</strong>puts, valuable growth <strong>in</strong>sights, aerial view <strong>of</strong> the competitive framework, <strong>and</strong> future market trends.<br />
We provide research services at a global as well as regional level; key regions <strong>in</strong>clude GCC, ASEAN, <strong>and</strong> BRIC.<br />
Our <strong>of</strong>fer<strong>in</strong>gs cover a broad spectrum <strong>of</strong> <strong>in</strong>dustries <strong>in</strong>clud<strong>in</strong>g Chemicals, Materials, Energy, Technology, Healthcare, <strong>and</strong><br />
Retail.<br />
We have a global presence with delivery centers across India specializ<strong>in</strong>g <strong>in</strong> provid<strong>in</strong>g global research reports <strong>and</strong> country<br />
research reports. FMI is headquartered out <strong>of</strong> London, U.K., with a state-<strong>of</strong>-the-art delivery center located <strong>in</strong> Pune, India.<br />
We comb<strong>in</strong>e our knowledge <strong>and</strong> learn<strong>in</strong>g from every corner <strong>of</strong> the world to distill it to one th<strong>in</strong>g – the perfect solution for<br />
our client.<br />
Research<br />
Capabilities<br />
• Customized Research<br />
• Syndicated Research<br />
• Investment Research<br />
• Social Media Research<br />
Subscription Information<br />
Sector Coverage<br />
For detailed subscription <strong>in</strong>formation please contact<br />
Hari. T (Sr. Manager - Global Bus<strong>in</strong>ess Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarket<strong>in</strong>sights.com<br />
• Automotive <strong>and</strong> Transportation<br />
• Chemicals & Materials<br />
• Electronics, Semiconductor, <strong>and</strong> ICT • Food <strong>and</strong> Beverages<br />
• Retail <strong>and</strong> Consumer Products<br />
• Services <strong>and</strong> Utilities<br />
• Industrial Automation <strong>and</strong> Equipment • Energy, M<strong>in</strong><strong>in</strong>g, Oil, <strong>and</strong><br />
• Healthcare, Pharmaceuticals & Medical <strong>Devices</strong> Gas
For other queries contact: Mr. Sudip Saha<br />
Future <strong>Market</strong> Insights: 616 Corporate Way, Suite 2-9018,<br />
Valley Cottage, NY 10989, United States<br />
T: +1-347-918-3531 | D: +1-845-579-5705<br />
Thank You!<br />
To know more about us, please visit our website:<br />
www.futuremarket<strong>in</strong>sights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarket<strong>in</strong>sights.com
Change language